From MarketBeat:



Meridian Wealth Management LLC has raised its holdings in Bristol-Myers Squibb by 86.5% during the third quarter. The institutional investor now owns 118,698 shares of the biopharmaceutical company’s stock worth $6,891,000. Other large investors such as Bank Julius Baer & Co. Ltd Zurich, BlackRock Inc., and State Street Corp have also made significant changes to their positions in the company. The stock is currently trading at $52.29 with a trading volume of 19,998,000 shares. The company also recently declared a quarterly dividend of $0.60 per share and has approved a share repurchase plan that allows the company to repurchase $3.00 billion in outstanding shares.

Additionally, CEO Christopher S. Boerner and Director Theodore R. Samuels II have purchased shares of the company’s stock in recent transactions. Bristol-Myers Squibb Company offers a range of biopharmaceutical products worldwide, including Eliquis, Opdivo, Pomalyst/Imnovid, and Orencia, among others. Despite holding a “Hold” rating among analysts, top-rated analysts have recommended five alternative stocks as better buys.



Read more: Bristol-Myers Squibb (NYSE:BMY) Shares Acquired by Meridian Wealth Management LLC